These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 11833414)

  • 1. Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.
    Ayton S; Lei P
    Biomed Res Int; 2014; 2014():581256. PubMed ID: 24527451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system.
    Wang J; Jiang H; Xie JX
    Neurochem Res; 2004 Dec; 29(12):2239-43. PubMed ID: 15672545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra.
    Jiang H; Song N; Wang J; Ren LY; Xie JX
    Neurochem Int; 2007 Jul; 51(1):32-6. PubMed ID: 17490790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease.
    Junxia X; Hong J; Wenfang C; Ming Q
    Exp Neurol; 2003 Aug; 182(2):483-9. PubMed ID: 12895460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between iron levels and degeneration of dopaminergic neurons in rat nigrostriatal system during the early 6-OHDA lesions in medial forebrain bundle].
    Wang J; Jiang H; Xie JX
    Sheng Li Xue Bao; 2003 Aug; 55(4):422-7. PubMed ID: 12937822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats.
    Wang J; Jiang H; Xie JX
    Eur J Neurosci; 2007 May; 25(9):2766-72. PubMed ID: 17561842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review.
    Pietracupa S; Martin-Bastida A; Piccini P
    Neurol Sci; 2017 Dec; 38(12):2095-2101. PubMed ID: 28866787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between dopamine and iron contents in the brain of parkinsonian rats].
    Jiang H; Chen WF; Xie JX
    Sheng Li Xue Bao; 2001 Oct; 53(5):334-8. PubMed ID: 11833414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.
    Deumens R; Blokland A; Prickaerts J
    Exp Neurol; 2002 Jun; 175(2):303-17. PubMed ID: 12061862
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.